TY - JOUR
T1 - Temporal evolution of myeloperoxidase and galectin 3 during 1 year after acute coronary syndrome admission
AU - Vroegindewey, Maxime M.
AU - van den Berg, Victor J.
AU - Bouwens, Elke
AU - Akkerhuis, K. Martijn
AU - Oemrawsingh, Rohit M.
AU - Asselbergs, Folkert W.
AU - Lenderink, Timo
AU - van der Harst, Pim
AU - Ronner, Eelco
AU - Umans, Victor A.W.M.
AU - Kardys, Isabella
AU - Boersma, Eric
N1 - Funding Information:
Declaration of interest statement: This work was supported by the Dutch Heart Foundation (grant number 2007B012), the Netherlands Heart Institute-Interuniversity Cardiology Institute of the Netherlands (project number 071.01) and the Working Group on Cardiovascular Research Netherlands, all of which are non-commercial funding bodies. An unrestricted research grant was further obtained from Eli Lilly, the Netherlands.
Publisher Copyright:
© 2019 Elsevier Inc.
PY - 2019/10
Y1 - 2019/10
N2 - Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers early after ACS admission and prior to a recurrent ACS event during 1 year follow-up.
AB - Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers early after ACS admission and prior to a recurrent ACS event during 1 year follow-up.
UR - https://www.scopus.com/pages/publications/85074498542
U2 - 10.1016/j.ahj.2019.02.016
DO - 10.1016/j.ahj.2019.02.016
M3 - Letter
C2 - 31053235
AN - SCOPUS:85074498542
SN - 0002-8703
VL - 216
SP - 143
EP - 146
JO - American Heart Journal
JF - American Heart Journal
ER -